PMCB
PharmaCyte Biotech IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$4.90M
P/E Ratio
—
EPS
$-2.22
Beta
0.66
52W High
$1.51
52W Low
$0.33
50-Day MA
$0.53
200-Day MA
$0.71
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
7.02
PEG Ratio
0.00
About PharmaCyte Biotech Inc
PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United States. The company is headquartered in Laguna Hills, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | -44.00% |
| Return on Assets | -8.35% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.07 |
| Price-to-Book | 0.17 |
| Price-to-Sales (TTM) | 12904.41 |
| EV/Revenue | 14270.44 |
| EV/EBITDA | -12.02 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $10.74M |
| Float | $10.07M |
| % Insiders | 5.74% |
| % Institutions | 7.11% |
Historical Volatility
HV 10-Day
111.31%
HV 20-Day
83.91%
HV 30-Day
71.38%
HV 60-Day
59.21%
HV Rank
—
Volatility is currently expanding
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on PMCB and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 9/26/2026